Enhancing Oncology Research with built-in KRAS Assay providers and RAS Assays
from the speedily evolving industry of oncology exploration, exact and productive mutation screening is critical for establishing focused therapies. The KRAS providers Platform performs a pivotal position With this landscape by featuring complete answers for KRAS mutation profiling and Investigation. KRAS mutations, located in about 95% of RAS-link